Skip to main content
NIH funding notice RFA-DA-21-002

Reducing Stigma Related to Drug Use in Human Service Settings (R21 Clinical Trial Optional)

Closed on August 11, 2020.

Posted
April 9, 2020
Close date
August 11, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $691,889 in first-year total cost, median $245,940.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 PXN-F (21)]3

Most frequent institutions

  1. OHIO STATE UNIVERSITY1
  2. RESEARCH TRIANGLE INSTITUTE1
  3. WASHINGTON UNIVERSITY1
Competing awards under RFA-DA-21-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Measuring resilience to intersectional stigma for people who inject drugs in need of HIV prevention1R21DA053708-01LANCASTER, KATHRYN ELIZABETHOHIO STATE UNIVERSITY, OH$249,074ZDA1
2021STRIDES (Strategies To Reduce Intersectional Drug usE Stigma): A mixed-methods, human-centered approach to address barriers to HIV services1R21DA053694-01BROWNE, FELICIA AMIRARESEARCH TRIANGLE INSTITUTE, NC$245,940ZDA1
2021Implementation of a Shared Decision-Making Aid for Reducing Stigma against Drug Use and HIV Harm Reduction in a Rural Setting1R21DA053710-01DURKIN, MICHAEL JOSEPHWASHINGTON UNIVERSITY, MO$196,875ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.